What a difference a year makes: reflections on the ACR recommendations for the medical management of osteoarthritis.
- 1 December 2001
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 3 (6) , 473-478
- https://doi.org/10.1007/s11926-001-0060-z
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hipCochrane Database of Systematic Reviews, 2006
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugsThe American Journal of Medicine, 2001
- Recommendations for the clinical use of cyclooxygenase-2–specific inhibitorsThe American Journal of Medicine, 2001
- Celecoxib versus diclofenac in the management of osteoarthritis of the knee: A placebo-controlled, randomised, double-blind comparisonScandinavian Journal of Rheumatology, 2001
- Tolerability profiles of rofecoxib (Vioxx®) and Arthrotec®: A comparison of six weeks treatment in patients with osteoarthritisScandinavian Journal of Rheumatology, 2001
- Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs: A 6-Week and a 1-Year Trial in Patients With OsteoarthritisArchives of Family Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Extracts from "Clinical Evidence": Non-steroidal anti-inflammatory drugsBMJ, 2000
- A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisGastroenterology, 1999
- Prevention of Peptic Ulcer and Dyspeptic Symptoms with Omeprazole in Patients Receiving Continuous Non-Steroidal Anti-Inflammatory Drug Therapy: A Nordic Multicentre StudyScandinavian Journal of Gastroenterology, 1996